











1150-9 A Beta Chemokine (MCP-1)-Induced Antigen- 
Independent Cellular and Not s Humoral Immune 
Response Can Be Stimulated After Stent Percutaneous 
Trensluminal Coronary Angioplaety 
Emanuel V. Eoonomg~, Christos Pitsavos, Anastasia Katinioti, Konstantinos Tedolouris, 
Athanasios Trikas, Madna Toutouza, Chdstodoulos Stafandis, Pavlos Toutouzas, Dept. 
Cardiol., Uni~ Athens, Hippokration Hospital, Athens, Greece. 
Background : The beta chemokines MCP-1 and RANTES activate and attract mono- 
cytes/macrophages and T-lymphocytes and thus, they can both stimulate antigen-inde- 
pendent cellular immune response. Autoantibodies to vascular endothelial damage- 
related externalized phosphatidylserine (aPS) or to its preferential cover annexin V 
(aANX-V), both indicate stimulation of humoral immune respone. Aim of this study was to 
delineate if any type of immune respone can be stimulated after acute coronary endothe- 
lial damage (CED)-related stent-percutaneous transluminal coronary angioplasty (stent- 
PTCA). Methods : 40 patients (pts) with coronary artery disease (CAD) underwent a pri- 
mary successful, single-vessel, stent-PTCA. 20 CAD pts who underwent only coronary 
angiography (CA) and 20 healthy subjects (HS) served as controls. Peripheral blood was 
sampled at besaline before and 24 hours after PTCA or CA as well as 3 and 6 months 
after PTCA and was evaluated for plasma levels of MCP-1, RANTES, aPS and aANX-V. 
Results : At baseline, PTCA pts presented plasma levels of MCP-1 (460±62 pg/mL) and 
RANTES (25.8±2.5 ng/mL) both similar to the respective levels of CA pts (MCP-1 : 
449±87 pg/mL and RANTES : 24.2±3.1 ng/mL) but higher than the respective levels of 
HS (MCP-1 : 97±12 pg/mL, p=0.002 and RANTES : 10.1±2.6 ng/mL, p=0.0001). After 
PTCA, only MCP-1 levels attained a gradual increase at all the interval times assessed 
(24h after : 618±78 pg/mL, 3m after : 676±78 pg/mL, 6m after : 714 ±64 pg/mL, p<0.05 in 
all cases compared with the corresponding value of the previous interval assessing 
time). No other changes in MCP-1 and RANTES levels were noticed after PTCA or CA at 
all the interval times assessed, in comparison to the corresponding levels before the 
respective procedure. Both aPS and aANX-V were undetectable in plasma of all PTCA 
pts, CA pts and HS, at any time assessed. Conclusions : In CED-related CAD, MCP-1 
and RANTES can both stimulate antigen-independent cellular immune response. How- 
ever, in acute CED-related stent-PTCA, only MCP-1 can stimulate such a response. 
There is not conclusive evidence that CAD or stent.PTCA are associated in an important 
way to stimulation of any CED-relatad humoral immune respone. 
1150-10 Alphs-Melanocyte Stimulating Hormone Inhibits 
Porcine Vascular Smooth Muscle and Endothelial Cell 
Responses to Tumor Necrosis Factor-Alpha 
John W. Havcock, Sheila MacNeil, Cathy M. Holt, Nadim Malik, Department of 
Engineering Materials, University of Sheffield, Sheffield, United Kingdom, Unit of Cardiac 
Physiology, Manchester Universi~ Manchester, United Kingdom. 
Background: The long-term success of percutaneous coronary interventions (PCI) is lim- 
ited by restenosis due to neointima formation. Early inflammation, apoptosis and prolifer- 
ation at the site of injury play a role in neointima formation. AIpha-melanocyte stimulating 
hormone (alpha-MSH) can inhibit inflammation by blocking intracellulg.r pathways trig- 
gered by several inflammatory cytokines in cells expressing MSH receptors (MC-1). 
Alpha-MSH has previously been demonstrated to inhibit NF-kB transcription factor acti- 
vation by TNF-alpha. However, the in vitro and in vivo effects of alpha-MSH on vascular 
smooth muscle ceils (VSMC) and endothelial cells are not known. 
Methods: Immuno-labelling of cultured porcine VSMC and endothelial cells has identified 
positive MC-1 receptor surface expression. Stimulation with human or porcine TNF-alpha 
induced NF-kB/p65 activation in both VSMC and endothelial ceils. NF-kB/p65 activation 
was determined by digital immunofluorescent nuclear tracking. 
Results: Alpha-MSH (10-9M) significantly inhibited TNF-arpha stimulated activation of 
.NF-kB by 50% (± 9%) in VSM cells and 48% (±10%) in endothelial ceils. Preliminary in 
vivo data obtained from oversize angioprasty injury to porcine coronary adery following 
local or systemic alpha-MSH delivery revealed a reduction in inflammation at the injury 
site one hour post-angioplasty. 
Conclusions: Our data suggests that alpha-MSH has potential for preventing local inflam- 
mation following angioplasty by inhibiting the NF-kB/p65 pro-inflammatory signalling 
pathway. Alpha-MSH inhibition of stenosis following PCI in pig arteries is presently being 
investigated. 
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850-1 The Influence of Intravascular Ultrasound Guidance on 
In-Hospital Outcomes After Stent Implantation: Results 
From the Brazilian Society of  In tarvent iona l  Cardiology 
Registry - CENIC 
Amanda Souse. Alexandre Abizaid, Gary Mintz, Luiz A. Mattos, Cantideo Campos, 
Angela Paes, Jamil Saed, Costantino Costantini, Gilvan Dourado, Hello Figueira, 
Klauber Carneiro, Alcides Zago, Expedito Ribeiro, J. Eduardo Souse, on behalf of 
CENIC Participants, Brazilian Society of Interventional Cardiology - CENIC, Sao Pauio, 
Brazil, institute Dante Pazzanese of Cardiology, Sac Paulo, Brazil. 
Background: It remains unclear if the use of intravascular ultrasound (IVUS-G) has any 
influence on the in-hospital Outcome after stenting (ST). 
Methods: From 1997 to 2000 a prospective clinical survey was made in 133 Brazilian 
Hospitals. In these Institutions 41,821 patients (pts) were treated with ST and were 
grouped according to IVUS-G or not. Logistic regression analysis was used to identify the 
independent predictors of in-hospital complications (death, myocardial infarction or 
urgent bypass surgery). 
Results: 
IVUS-G No IVUS-G p 
Number of Patients 2,359 (5.6%) 39,462 (94.4%) 
Age (y) 59.7 ± 10.9 60.7 + 11.1 < 0.001 
Male (%) 70.4 69.9 0.585 
Diabetes (%) 16.5 17.1 0.488 
Unstable Angina (%) 24.0 21.1 0.001 
Angiographic Thrombus (%) 18.8 20.1 0.068 
Angiographic Calcium (%) 31.4 19.0 < 0.001 
Residual Stenosis (%) 8.3 ± 10.8 10.6 ± 11.6 < 0.001 
Procedural Success (%) 98.9 98.6 0.213 
In-hospital Death (%) 0.4 1.1 0.002 
In-hospital MI (%) 0.6 1.0 0.066 
In-hospital Death/MI (%) 0.9 1.8 0.001 
The independent predictors of in-hospital complications were: the use of IVUS-G (Odds 
Ratio 0.55; 95% CI 0.35 - 0.87; p = 0.0108), age (p < 0.001), thrombus (p < 0.001), % DS 
post ST (p < 0.001). 
Conclusions: In a large multicentar egistry of 41,821 pts in 133 centers, IVUS guidance 
was associated with: (1) lower residual stenosis, and (2) fewer in-hospital complications 
(including death and MI) despite increased patient and lesion complexity. 
10:45 a.m. 
850-2 Anglography Versus Intravascular Ultrasound-Directed 
Stent Placement: A Cost Analysis From AVID 
Robert J. Russo, Patricia D. Silva, The AVID Investigators, Scripps Clinic, La Jolla, 
California. 
Background: AVID (Angiography Vs. Intravascular ultrasound [IVUS]-Diracted stent 
placement) is a multicenter randomized trial to determine the effect of IVUS-directed stent 
placement on clinical outcome. Results include a 12-month target lesion revasculadzation 
(TLR) rate of 4.9% in the IVUS group and 10.8% in the angiography group when protocol 
violations are excluded (p=0.02). 
Methods: To determine the cost of IVUS- and angiography-diracted stent placement, 
resource utilization was assessed for both groups within 12 months. Acute procedural 
resource utilization included the cost of IVUS catheters, PTCA balloons, stents and proce- 
dure time related to IVUS-dirocted additional therapy. Post-procedure costs included in- 
hospital complications, as well as readmission for MI, repeat coronary angiography, and 
repeat PTCA or CABG for TLR within 12 months, Medicare hospital reimbursements for 
MI, unstable angina, coronary angiography, PTCA, and CABG were obtained for 10 clinical 
sites and adjusted using institution-specific cost-to-charge ratios. Medicare schedules were 
used for physician fee reimbursement rates. Costs were compared using a two-sample t- 
test. 
Results: At 24 centers 800 patients were randomized--394 to IVUS and 406 to angiogra- 
phy, The mean number of 15ram stents used was 1.5±0.9 in the IVUS and 1.4±0.7 in the 
angiography group (p=0.01). In the IVUS group, 42% required additional therapy to fulfill 
criteria; 29% for an underdilated stent. The mean acute procedural cost per patient in the 
IVUS group was $863 greater than the angiography group ($3528±1351 vs. $2645±1122; 
p<0.01 ), The mean pest-procedure cost per patient due to procedural complications, hospi- 
tal readmission, repeat angiography and PTCA/CABG for TLR was $1329±2939 in the 
IVUS and $1629±3219 in the angiography group (p=0.27). The 12-month cumulative cost 
was $4857±3240 in the IVUS group and $4274±3516 in the angiography group (p=0.05). 
Conclusions: IVUS-directed slant placement results in significantly lower 12-month TLR 
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rates. However, no cost advantage is noted with IVUS-gulded stent placement when acute 
procedural costs and TLR-associated costs are compared with anglegraphy-guided stent 
placement. 
11:00 a,rn. 
8~>0-3  Cost-Effectivenses of Intracoronary Ultrasound for  
Percutsneous Coronary Interventions: Economic 
Analysis of the Randomized SIPS Trial 
Christian Mueller, John M. Hodgson, Heinz J. Buettner, Stephan Marsch, HeLmut 
Roskamm, Herz-Zentrum, Bad Krezingan, Germany, University Hospital, Basel, 
Switzerland. 
Background: The SIPS-trial included a prospectively designed economic analysis to investi- 
gate whether outine IVUS-guidance intervention iscost-effective. 
Methods: Consecutive patients (n=269) with 356 lesions were randomly assigned to receive 
previsional stenting with angiographlc guidance only (ANGLO) or with IVUS guidance. 
Results: The two-year MACE free survival (effectiveness) was significantly higher in the 
WUS-gulded group (80% versus 69%, p=0.04). In-hospital costs for procedural personnel, 
capital and disposable equipment were higher in the IVUS group. This was offset by lower 
costs for inpatient care and urgent arget vessel revasculadzation i the IVUS group. There- 
fore, total in-hcepltat cost was comparable [$5245e.2256 (IVUS) versus $4776¢2961 
(ANGLO), S/patient, p=0.15]. During two-year follow-up costs for cardiac hospitalizations, 
medication and indirect costs were similar. This resulted in identical total costs over the two- 
year period [$15.947¢8545 (IVUS) versus $15.103±9954 (ANGLO), S/patient, p=0.89]. The 
cost-effectivenass ratio calculated to $19.823 par MACE-free survival with IVUS and to 
$23.190 par MACE-free survival with ANGLO. Bootstrapping revealed a 61% probability of 
IVUS being less expensive and more effective (Figure). Sensitivity analysis showed that the 
cost-effectiveness of IVUS was robust o changes in several variables. 
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850-4 Do Intravascular Ultrasound Predictors for  Target 
Lesion Revascularlzetion Apply to Saphenous Vein 
Grafts? 
Marco T. Ceataona. Gary S. Mintz, Ellen Pinnow, Akiko Maehara, Javed M. Ahmed, 
Euganio Stabile, Natalie Gevoddan, Danlele Claus, Marfina Gillerd, William O. Soddath, 
Lowell F. Satier, Augusto D. Pichard, Nell J. Weissman, Washington Hospital Center, 
Washington, Dist of Columbia, Cardiovascular Research Foundation, New York, New York. 
Background: Previous studies have defined the predictors of target lesion revascular- 
ization (TLR) after stent implantation in native coronary arteries to include intravascular 
ultrasound (IVUS) reference lumen dimensions and lesion site plaque burden, remodel- 
ing, and final lumen dimensions.Methods end Results: To determine whether these pre- 
dictors of TLR also apply to sapbenous vein graft (SVG) stanoses, we reviewed the IVUS 
findings in 313 SVG lesions in 275 pts before and after stent implantation. Lesion and 
proximal and distal reference measurements included external elastic membrane (EEM), 
lumen, and plaque (EEM-lumen) areas. Lesion site remodeling index was determined by 
dividing lesion EEM by average reference segment. Positive remodeling was defined 
>1.0 and intermediate/negative r modeling as _<1.0. Baseline characteristics uch as 
gender, hypertension, diabetes, tobacco use, hypercholesterolemie, renal insufficiency 
(craatinina serum level >1.2), family history, and lesion site location (anastomosis, SVG 
body and ostium) were similar in the lesions with and without TLR. IVUS findings are 
shown in the Table. Importantly, these IVUS measurements also did not predict CK-MB 
elevation after stent implantation. 
Conclusion: Conventional IVUS predictors of TLR in native artedas do not apply to SVG 
lesions treated with stant implantation. 
TLR NoTLR p 
N=31 lesions N=179 lesions 
Average Reference Lumen CSA mm 2 9.74±3.26 11.16±4.81 0.11 
Average Reference Plaque Burden (%) 32±5 33±7 0.7 
Lesion Plaque Burden (%) 68±9 71 ±13 0.20 
Average References Plaque CSA mm 2 4.84±2.09 5.57±2.69 0.15 
Final Lumen CSA mm 2 7.34±2.58 8.35±3.0 0. t 1 
Positive Remodeling 6 (20%) 35 (20'/0) 1.0 
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850-5 Intravascular Ultrasound Guidance Optimizes Cuffing 
Balloon Angloplasty 
yuzuru Takado, Sam Bastani, Oren T. Guftman, Jesse W. Currier, Lawrence A. Yeatman, 
Kathy McCIoy, Annette Davis, Devendra K. Vora, Jonathan M. Tobis, UCLA Center for 
Health Sciences, Los Angeles, California. 
Background. The purpose of the present study was to test whether intravascular ultra- 
sound (IVUS) guidance for Cutting Balloon (CB) angioplesty could improve the acute 
results of percutanaous coronary interventions (PCI). IVUS guidance may be useful dur- 
ing PCI to optimize angiographic results compared with angiographic guidance alone. 
When using the CB, accurately sizing the device may enhance the dilatation effect yet 
protect against the risk of perforation. 
Methods. CB angioplasty was used on 151 coronary artery lesions from 103 patients. 
The coronary lesions were classified into 2 groups: IVUS guided or angiographic guid- 
ance alone. 
Results. The initial CB success rate was 89% (the CB would not pass through 14 
lesions). In 135 successful esions, the IVUS guided group had a significantly larger MLD 
and less % diameter stenceis than the angiographic guided group. 78 lesions were also 
treated with stents (IVUS guided 37, angiography alone 41). The IVUS guided stent 
group had a larger MLD (3.0-zO.3 ram) than the angiographlc group (2.8-tO.6 mm, p<0.05) 
despite similar reference diameters. One coronary perforation occurred in the angio- 
graphic guidance group. 
Conclusion. By performing IVUS pdor to PCI, the size of the CB can be matched to the 
media diameter thus optimizing the results compared to angiographic guidance alone. 
When the CB diameter is based on IVUS measurements, these improved results may be 
obtained without an increased risk of perforation. 
Cutting Balloon IVUS guided Angiography alone p value 
# of lesions 63 72 
Reference diameter (mm) 2.9-/0.5 2.8:L~.6 n.s. 
MLD (mm) before 0.7:L~.5 0.7i-0.5 n.s. 
after CB 2.1:t:0.5 1.9t"0.5 p<0.05 
final 2.8L~0.4 2.5~0.6 p<0.05 
11:45 a .m.  
850-6 Intravascular Ultrasound Guidance Decreases Target 
Lesion Revaacularizetion in Long-Dif fuse Coronary 
Lesions 
Andrea S. Abizaid, Roxana Mehran, Alexandra J. Lansky, George Dangas, Alaxandrs 
Abizaid, Mohamed Mohamed, Izat Hjazi, Gregg W. Stone, Martin B. Leon, Lenox Hill 
Heart & Vascular Institute, New York, New York, Cardiovascular Research Foundation, 
New York, New York. 
Background: Stenting of long lesions improves procedural results and reduces late recur- 
rence when compared to balloon angioplasty. However, most previous studies have used 
angiographic guidance during stent implantation. Methods: We analyzed 879 patients 
with long lesions (>_20ram) in native coronary arteries that were treated with stent implan- 
tation, 673 with intravascular ultrasound (IVUS)-guidanco (n=673) vs 206 with anglo- 
graphic guidance. Results: Baseline charactaristics (including diabetes and vessel size) 
and major in-hospital complications were similar between the two groups (Table). Proce- 
dural details and acute angiographic and long-term clinical results are shown (Table). 
Conclusions: By using larger slants/balloons at higher pressures, IVUS-guidance during 
stenting of pts with long lesions achieved a superior sngiographic result. This translated 
into a significant improvement in late clinical outcome even though IVUS-guidance 
resulted in implanting more stents/lasion. Thus, it is not the amount of slant metal, but the 
lumen size that determines the need for repeat revasculadzation. 
IVUS-guided Anglo-guided p 
Diabetes, % 34% 35% 0.8 
LAD, % 26% 22% 0.2 
# of stents,n 1.6±0.8 1.3±0.7 0.0001 
Maximum stont/balloon size, mm 1.1 ±0,3 1.0±0.2 0.001 
Maximum inflation pressure, arm 14.5±3.9 12.2±4.3 0.0001 
Angiography 
Lesion length, mm 24±9 25±10 0.16 
Reference diameter, (mm) 3.1±0.8 3.2±1.1 0.4 
Final MLD, mm 2.7±0.9 2.5±1.2 0.04 
Final DS 11±9 20±11 0.0001 
6-month TLR, % 14 20 0.05 
MLD=minimum lumen diameter, DS=diameter stenosis, TLR=target lesion 
revascularization 
